Investigators develop activated T cell therapy for advanced melanoma
Research by UH Seidman Cancer Center published in Journal of Immunotherapy leads to launch of clinical trial
2015-07-07
(Press-News.org) CLEVELAND - T cells from patients with melanoma can trigger a protective immune response against the disease according to a new study out of University Hospitals Case Medical Center Seidman Cancer Center and Case Western Reserve University School of Medicine.
Published in the July/August issue of Journal of Immunotherapy, these new findings demonstrate that T cells derived from lymph nodes of patients with melanoma can be expanded in number and activated in the laboratory for intravenous administration in the treatment of patients. Led by Julian Kim, MD, Chief Medical Officer at UH Seidman Cancer Center, the research team has developed a novel technique to generate large numbers of activated T cells which can be transferred back into the same patient to stimulate the immune system to attack the cancer.
"This study is unique in that the source of T cells for therapy is derived from the lymph node, which is the natural site of the immune response against pathogens as well as cancer," says Dr. Kim who is also Professor of Surgery at Case Western Reserve University School of Medicine and the Charles Hubay Chair at UH Case Medical Center. "These encouraging results provide the rationale to start testing the transfer of activated T cells in a human clinical trial."
In his research laboratory at the School of Medicine, Dr. Kim and his team developed a new method to grow and activate immune cells in a two-week culture. Immune cells are extracted from lymph nodes which have been exposed to growing melanoma in the patient's body. Rather than trying to activate the T cells while in the body, the lymph nodes are surgically removed so that the activation process and growth of the T cells can be tightly regulated in a laboratory. This novel approach to cancer treatment, termed adoptive immunotherapy, is only offered at a few institutions worldwide.
These promising findings have led to the recent launch of a new Phase I human clinical trial at UH Seidman Cancer Center in patients with advanced melanoma. The research leading to the clinical trial was funded by the National Institutes of Health and the Case Comprehensive Cancer Center. The new Phase I clinical trial is being supported by University Hospitals as well as a significant philanthropic effort including the Immunogene Therapy Fund, Paula and Ronald Raymond Fund and the Kathryn and Paula Miller Family Fund.
"The infusion of activated T cells has demonstrated promising results and is an area of great potential for the treatment of patients with cancer," said Dr. Kim. "We are really excited that our method of activating and expanding T cells is practical and may be ideal for widespread use. Our goal is to eventually combine these T cells with other immune therapies which will result in cures. These types of clinical trials place the UH Seidman Cancer Center at the forefront of immune therapy of cancer."
Additionally, the research team has been researching the possibility of using lymph nodes from patients with pancreatic cancer to develop T cell therapy. Their goal is to expand the program and eventually study other tumor types including lung, colorectal and breast cancers.
INFORMATION:
Study co-authors include the primary and secondary authors Mei Zhang and Hallie Graor as well as Anthony Visioni, Madeleine Strohl, Lu Yan and Kevin Caja
About University Hospitals
University Hospitals serves the needs of patients through an integrated network of hospitals, outpatient centers and primary care physicians. At the core of our health system is University Hospitals Case Medical Center. The primary affiliate of Case Western Reserve University School of Medicine, University Hospitals Case Medical Center is home to some of the most prestigious clinical and research centers of excellence in the nation and the world, including cancer, pediatrics, women's health, orthopedics and spine, radiology and radiation oncology, neurosurgery and neuroscience, cardiology and cardiovascular surgery, organ transplantation and human genetics. Its main campus includes the internationally celebrated UH Rainbow Babies & Children's Hospital, ranked among the top children's hospitals in the nation; UH MacDonald Women's Hospital, Ohio's only hospital for women; and UH Seidman Cancer Center, part of the NCI-designated Case Comprehensive Cancer Center at Case Western Reserve University. University Hospitals Case Medical Center is the 2012 recipient of the American Hospital Association - McKesson Quest for Quality Prize for its leadership and innovation in quality improvement and safety.
For more information, go to http://www.uhhospitals.org
About Case Western Reserve University School of Medicine
Founded in 1843, Case Western Reserve University School of Medicine is the largest medical research institution in Ohio and is among the nation's top medical schools for research funding from the National Institutes of Health. The School of Medicine is recognized throughout the international medical community for outstanding achievements in teaching. The School's innovative and pioneering Western Reserve2 curriculum interweaves four themes--research and scholarship, clinical mastery, leadership, and civic professionalism--to prepare students for the practice of evidence-based medicine in the rapidly changing health care environment of the 21st century. Nine Nobel Laureates have been affiliated with the School of Medicine.
Annually, the School of Medicine trains more than 800 MD and MD/PhD students and ranks in the top 25 among U.S. research-oriented medical schools as designated by U.S. News & World Report's "Guide to Graduate Education."
The School of Medicine's primary affiliate is University Hospitals Case Medical Center and is additionally affiliated with MetroHealth Medical Center, the Louis Stokes Cleveland Department of Veterans Affairs Medical Center, and the Cleveland Clinic, with which it established the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University in 2002. http://casemed.case.edu
ELSE PRESS RELEASES FROM THIS DATE:
2015-07-07
If you're seeing more goat meat in grocery stores and on restaurant menus these days, you can probably chalk it up to a particular expression of ethnic identity--an expression that has important implications for immigrants, marketers, and policymakers, according to a recent study in the Journal of Public Policy & Marketing.
"Goat meat is becoming more popular in America, and in large part it's been due to the desire of immigrants to retain the tastes and preferences of their country of origin," write the authors of the study, Denver D'Rozario and Guang Yang (both at Howard ...
2015-07-07
NASA's Aqua satellite passed over Typhoon Nangka on July 6 and took an infrared look at the large storm as it strengthened from a tropical storm into a typhoon.
The Atmospheric Infrared Sounder or AIRS instrument aboard NASA's Aqua satellite gathered infrared temperature data on Nangka on July 6 at 15:11 UTC (1:11 p.m. EDT). The infrared data showed a large storm with the bulk of thunderstorms east of the low-level center. The 20 nautical-mile-wide (23 miles/37 km) eye of the storm is also visible on the image.
Fragmented bands of powerful thunderstorms surrounded ...
2015-07-07
Bringing reusable bags to the grocery store often means you are an environmentally friendly shopper. But it also influences the very things you buy. According to a new study in the Journal of Marketing, bringing your own bags makes you more likely to purchase organic food--and junk food as well.
"Grocery store shoppers who bring their own bags are more likely to purchase organic produce and other healthy food. But those same shoppers often feel virtuous, because they are acting in an environmentally responsible way. That feeling easily persuades them that, because they ...
2015-07-07
The competition for customers in the service sector is fierce, and new customers are entering the market all the time. So when a company such as Time Warner, Travelocity, or AT&T loses a customer, is it worth it to try to win that customer back? Yes, says a new study in the Journal of Marketing.
"Our results show that lost customers, if won back, can be profitable to a company and that so-called win-back initiatives are worth the time and effort," write V. Kumar (Georgia State University), Yashoda Bhagwat , and Xi (Alan) Zhang (both Georgia State University). "In particular, ...
2015-07-07
If you feel particularly annoyed when Michelin raises the prices of their tires, blame the Michelin Man. According to a new study in the Journal of Marketing, companies whose brands are represented by or associated with human or humanlike figures (think the Michelin Man or Colonel Sanders or Mrs. Paul) are often perceived to be taking advantage of consumers when they raise their prices.
"When brands are humanized, consumers attribute human motives to those brands. Consumers are more likely to see price increases in those brands as the result of a manager trying to see ...
2015-07-07
Inside Gramercy maximum security prison, the market for nearly any kind of good or service is extremely limited, to say the least. But according to a new study in the Journal of Public Policy & Marketing, the severely restricted consumption choices faced by the 3,000 or so inmates at Gramercy create opportunities to pursue innovative and entrepreneurial business ventures.
"The men at Gramercy quickly come to understand that the formal system of exchange, from public provision of goods and services to the commissary, is primarily responsive to needs of third parties such ...
2015-07-07
In the most inclusive study to date on friendship, Chapman University research looks at gender, age, and sexual orientation differences in the number of friends people rely on for support, to what extent they choose friends of the same gender, and overall life satisfaction. In a survey of more than 25,000 participants from all walks of life, this study examines at how U.S. adults rely on friends for expressive, instrumental and companionate support. Specifically, how many same-gender and cross-gender friends people have who they can talk to about their sex life, who they ...
2015-07-07
Over a billion entrepreneurs in the world operate in subsistence economies, often living hand to mouth. Is there a relationship between such poverty and entrepreneurial activity? A new study in the Journal of Public Policy & Marketing says yes and sheds light on the way in which two kinds of constrained consumption spur--or in some cases impede--entrepreneurial activity.
"There is a complex interplay when it comes to entrepreneurship between what we define as 'chronic' constrained consumption and 'periodic' constrained consumption," write the authors of the study, Srinivas ...
2015-07-07
In a study that included nearly 24,000 participants, those who experienced a stroke had an acute decline in cognitive function and also accelerated and persistent cognitive decline over 6 years, according to an article in the July 7 issue of JAMA.
Each year, approximately 795,000 U.S. residents experience a stroke. In 2010, almost 7 million adults were stroke survivors. Cognitive decline is a major cause of disability in stroke survivors. The magnitude of survivors' cognitive changes after stroke has been uncertain, according to background information in the article.
Deborah ...
2015-07-07
In an analysis that included nearly 1.2 million participants and more than 135,000 deaths, mortality associated with a history of diabetes, stroke, or heart attack was similar for each condition, and the risk of death increased substantially with each additional condition a patient had, according to a study in the July 7 issue of JAMA.
The prevalence of cardiometabolic multimorbidity (defined in this study as a history of 2 or more of the following: diabetes mellitus, stroke, myocardial infarction [MI; heart attack]) is increasing rapidly. Considerable evidence exists ...
LAST 30 PRESS RELEASES:
[Press-News.org] Investigators develop activated T cell therapy for advanced melanoma
Research by UH Seidman Cancer Center published in Journal of Immunotherapy leads to launch of clinical trial
